Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: TWIST1's Role in Activating Cancer Stem Cell Markers and Facilitating Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma

  • By

  • Sima Ardalan Khales

  • Sina Mozaffari‑Jovin

  • Dirk Geerts

  • Mohammad Reza Abbaszadegan

  • September 11, 2026

Share

Clinical Scorecard: Correction Notice: TWIST1's Role in Activating Cancer Stem Cell Markers and Facilitating Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma

At a Glance

CategoryDetail
ConditionEsophageal Squamous Cell Carcinoma
Key MechanismsTWIST1's role in activating cancer stem cell markers and facilitating epithelial-mesenchymal transition.
Target PopulationPatients with esophageal squamous cell carcinoma.
Care SettingOncology research and clinical settings.

Key Highlights

  • Article retracted due to concerns about data integrity.
  • Similarities identified between cell images in various figures.
  • Authors did not address the concerns raised by the Editors.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content